top of page
Dtrip4H-blue.png

Funded by the European Union (DTRIP4H, No. 101188432). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the granting authority. Neither the European Union nor the granting authority can be held responsible for them. 

EN_FundedbytheEU_RGB_WHITE.png

@DTRIP4H CONSORTIUM

Copy of linkedin-icon_edited.png
Copy of x-icon_edited.png
Copy of youtube-icon_edited.png
Copy of linkedin-icon_edited.png
Copy of x-icon_edited.png
Copy of youtube-icon_edited.png

DTRIP4H Use Case 2 Team Meets in the Netherlands

Teamwork in Progress: Advancing DTRIP4H Use Case 2

DTRIP4H project partners from Sync Biosystems (part of the Demcon group) and the University of Helsinki met (3–4 November 2025) in Leiden to advance Use Case 2 (the VR Drug Combiner), aligning validation strategies and data formats to accelerate AI-guided combination therapy research.

📊 The team also aligned on data exchange formats, prediction schemas, and the project timeline to ensure smooth integration across partners.

Many thanks to our partners for capturing these moments of collaboration and sharing a glimpse of the inside work behind DTRIP4H!

In the photo:
Berend van Meer
Clara Ferrer Castellà
Jing Tang
Jie Bao
Qinhan Hou

Next
bottom of page